Uncategorized
iClick Interactive Asia Group Limited (NASDAQ: ICLK), a China-based company, has shared the results of its annual shareholder general meeting; the meeting was held Dec. 23, 2020, in Hong Kong. During the meeting, iClick shareholders approved and ratified the appointment of a new director. Subsequent to the meeting, it was announced that Matthew Chu Pong Fong had been ratified as a director of the independent online marketing and enterprise data solutions provider. iClick is committed to connecting worldwide marketers with potential target audiences located in China, the largest country in the world by population and the fourth largest country in the world by geography. The company has a worldwide presence, with 10 operating locations scattered globally, including in Asia and Europe.
To view the full press release, visit http://ibn.fm/YhM6P
About iClick Interactive Asia Group Limited
iClick Interactive is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide including Asia and Europe. For more information about the company, please visit www.iClick.com.
NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into a securities purchase agreement with a single healthcare-dedicated institutional investor. The agreement outlines the purchase and sale of 3,116,884 shares of Genprex common stock; the purchase price of those shares will be $3.85 per share in a registered direct offering priced at-the-market under Nasdaq rules. The agreement, which is expected to close on or before Dec. 24, 2020, also stipulates that no warrants will be issued in connection with the transaction. The offering closing is subject to the satisfaction of customary closing conditions. Sole placement agent for the offering is A.G.P./Alliance Global Partners. Interested parties are encouraged to read all the information regarding the offering; all required and pertinent information has been filed with and is available from the U.S. Securities and Exchange Commission (“SEC”).
To view the full press release, visit http://ibn.fm/sNz3D
About Genprex Inc.
Genprex is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, GPX-001 (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). GPX-001 has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. GPX-001 has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted fast track designation for GPX-001 for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with “EFGR” mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com
NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
IntelliSense.io recently had an event that centered on a discussion around mining processes and technology and the future of mining. The session included BHP’s head of innovation Cleve Lightfoot, senior VP of Oilfield & Mining solutions Damien Caby; Ippei Akiyoshi of the CVC Mineral Resources Group; and Sam G Bose, CEO and founder of IntelliSense.io.
The themes discussed during the forum focused on why the mining industry requires change, what the industry would look like in the future and how the industry could adopt innovation. At the center of this discussion was the view that mining processes and technology were out of date.
Lightfoot expounded on this, stating that the industry was working with processes and technology that were developed nearly a century ago, which makes those processed and technology unsuitable for the future of the mining industry. He added that while the technology was more efficient as well as bigger and better, the industry had not taken into account how operations in the mining industry had changed and the fact that it would continue changing at a more rapid pace.
Bose said that sustainability solutions had become an immediate need for the mining industry as advanced technologies were developed. He stated that the next-generation miners were more vocal on this change as it would enable mining to occur in a way that was more sustainable. Additionally, he added that new miners entering the industry were looking into various systems that would allow them to access information instantaneously, which would allow them to make decisions using data in real time. This, he said, had also acted as an incentive for the industry to explore alternative ways of operation.
Akiyoshi of Mitsubishi supported this view, adding that investors were also keenly interested in the environmental consciousness of mining firms. He stated that developing a good economic value was good but that mining firms needed to demonstrate that they not only cared for the environment but were also responsible in how they carried out their operations.
Caby from BASF chimed in, stating that from an operational viewpoint, the demand for material that was environmentally-conscious and ethically sourced had also influenced the direction of the natural resource industry significantly. He explained that this was the largest driver of change as it would shift the way most minerals would be extracted from the earth.
He then suggested that moving forward, companies would need to prioritize their opportunities, which would include understanding the situations of their own mines and unlocking their operational data value before they began their innovation journey.
Speaking of technological transformation, Energy Fuels Inc. (TSX: EFR) (NYSE American: UUUU) has three facilities at which it leverages two key technologies —in-situ recovery and conventional extraction methods — to excel at mining uranium.
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
Wrap Technologies (NASDAQ: WRAP), an innovator of modern policing solutions, today announced international reorders and a growing number of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, WRAP recently received several international reorders totaling over 600 BolaWrap devices, plus cartridges and accessories. The company also received over 50 new orders and more than 15 reorders for domestic law enforcement agencies over the last thirty days. “Despite the social, political, financial and health care challenges seen by law enforcement in 2020, we are proud of the commitment our partner agencies are making to increase public safety and safely de-escalate potentially higher levels of force,” said Tom Smith, president and interim CEO of WRAP Technologies. “We are seeing increases in both agency adoption and successful field deployments, signaling what we believe is part of a changing tide in the way law enforcement approaches non-compliant but non-violent subjects.”
To view the full press release, visit https://ibn.fm/8jptl
About Wrap Technologies Inc.
Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information about the company, please visit www.WRAP.com.
NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at http://ibn.fm/WRAP
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Individuals who are caught with marijuana for personal use in Northern Ireland will not be prosecuted or have a criminal record and will instead be dealt with under the adult-caution system, which was established more than a decade ago. However, this only applies to individuals who haven’t been caught repeatedly with personal-use marijuana or people who have not been caught with bigger marijuana shipments.
Among the four new offenses added to the adult-caution scheme include the possession of personal-use cannabis. The objective of this is to free up resources of the court and Garda, the national police force, while dealing with offenders in a more informal setting. This is a pioneer moment given that this will be the first time that an illicit drug’s offense will be dealt with using a prosecution-based process instead of through the conventional criminal justice system.
The purpose of the adult-caution scheme is to eliminate the threat of a criminal record for individuals who are first-time offenders or those who have committed offenses that can be considered as relatively minor. Garda Headquarters, located in Phoenix Park, recently stated that possession of personal-use marijuana had been included in the adult-caution scheme just days ago.
Following an agreement with the director of public prosecutions, a couple of other offenses were included as well, including the breaching the control-of-access-to-certain-events clause found in the Public Order Act. Trespassing in a manner that may give rise to fear or casual trading contrary to one’s license terms or without a license were also added to the caution scheme.
Last year, the minister of health at the time, Simon Harris, announced the state’s plans to add possession of herbal marijuana or marijuana resin to the adult-caution scheme, highlighting that this move would affect nearly 12,000 individuals annually who are caught by the Garda for possession of drugs for personal use. He explained that instead of being processed under the criminal justice system, roughly 10% of these cases would be referred for therapy and further treatment under the new system.
However, in the drug policy report that was released at around the same time, a Garda Síochána declared that they were against multiple adult cautions, arguing that illicit drug users could exploit the new scheme. The Garda observation stated that couriers and drug dealers alike may begin carrying drugs in small quantities, with the knowledge that they are allowed to possess a quantity of drugs for personal use.
Some companies in North America have opted to make products that are fall within the laws governing cannabis. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) has added a collection of CBD-infused edibles and topicals to its line of products.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
- SGTM brings environmentally friendly, sustainable approach to tree and storm waste disposal
- Company processes its tree debris into variety of organic mulch products, was recently awarded contracts to market its products through The Kroger Co., Circle K stores
- SGTM recently awarded IPEMA certification to commence recycling waste into playground surfacing material sector, which is expected to be valued at over $5.8 billion by 2026
- Active 2020 hurricane season has led to increased demand for SGTM’s storm, tree recovery services
Sustainable Green Team (OTC: SGTM) has historically sought to provide a synergistic and environmentally beneficial solution to tree and storm waste disposal, helping to alleviate the environmental burdens which have traditionally afflicted landfills and disposal sites around the country. Accordingly, throughout its 40-year corporate tenure, SGTM has prided itself in building a reputation as an environmentally responsible enterprise, focused on being “stewards of the environment” across all aspects of its business.
Sustainable Green Team’s vertically integrated operations have been founded around the central tenet of sustainability—a trait which has been prevalent across all facets of its operations. Following the collection of tree debris through its tree services division and collection sites, the company subsequently transfers the amassed tree biomass through to the processing divisions for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products, which are then packaged and sold to retailers, landscapers and for general agricultural purposes.
SGTM has found a willing audience for its products, revealing recently that its subsidiary, Mulch Manufacturing Inc., had been awarded contracts to supply The Kroger Co. and Alimentation Couch-Tard’s Circle K subsidiary with premium grade organic mulch products over the coming year (https://ibn.fm/0AJnV).
“We have been blessed to be offered these amazing opportunities from large chain accounts to help further expand our brand and overall exposure,” stated SGTM CEO and Director Tony Raynor (https://ibn.fm/OctuN).
In addition to its efforts in recycling tree and storm waste into commercialized mulch products, the Sustainable Green Team has recently gained the International Play Equipment Manufacturers Association (“IPEMA”) certification to commence recycling waste into playground surfacing material. With a growing demand for playground surfacing material from schools, commercial athletic facilities and recreational spaces, SGTM’s new product line is expected to help the company tap into a market estimated to rise to a value of over $5.8 billion by the end of 2026, a 150% increase from 2017’s $3.7 billion (https://ibn.fm/vqDhT).
The 2020 Atlantic hurricane season was destined for the record books before it even started. Meteorologists began calling for an above-average storm season as early as December 2019 (https://ibn.fm/WzeZ7), with predictions of 15-20 named storms and four major hurricanes. However, eclipsing initial forecasts, the Atlantic hurricane season has thus far been comprised of 30 tropical storms, 13 hurricanes and six major hurricanes with initial assessments estimating the cumulative economic impact of the storms at an estimated $38 billion (https://ibn.fm/3LjQT).
The active storm season has led to a commensurate increase in the demand for tree recovery/collection services which has translated into greater sales for the company’s end products.
“Getting paid for your feedstock in the mulch business is a recipe for success and great profit margins,” said Raynor. “Storm recovery is a multibillion-dollar business, and we are prepared to help in any cleanup process.”
To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/EBY3V.
NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
Last week, the Food and Drug Administration (FDA) announced that it had approved the first over-the-counter (OTC) home-sample collection kit for the coronavirus. The coronavirus test collection kit — LabCorp Pixel kit — is permitted for use by people aged 18 years and above and can be used without a prescription. The testing kit includes a nasal swab, which will be used to collect a sample at home. The self-collected sample can then be sent out to be tested at LabCorp.
Test users will then receive their test results either through an online portal, a phone call from their health-care provider or email. If test results are negative, they will be delivered through the user online portal or via email. However, if an individual’s test results are invalid or positive, the results will be delivered to the individual via a phone call from a health=care provider.
Using this home-sample collection kit eliminates the need to leave your house to get tested, which exposes an individual to various risk factors. The FDA states that the home-collection kit allows its users to learn more about their coronavirus infection status, which could help in determining whether quarantining oneself would be an appropriate measure. The kit would also assist an individual’s health-care professional to make the appropriate decision concerning their patient or give proper advice on measures to be taken.
In another news release by the FDA, Jeff Shuren, the director of the Center for Devices and Radiological Health, explained that currently several home-collection kits are available for prescription using an online questionnaire. However, the newly approved home-sample collection kit makes it easier for individuals to obtain samples and send those samples to a lab for processing, without having to fill out a questionnaire and await a prescription.
Earlier this month, the FDA also reported that an at-home diagnostic test that could be used to collect samples of influenza B and A as well as the coronavirus had been approved. The Quest Diagnostics Self-Collection Kit for the flu and coronavirus and the Quest Diagnostics Flu and coronavirus reverse transcription PCR test can be used by individuals who suspect that they may have a respiratory viral infection with the coronavirus; both are available to the public and can be obtained using a prescription.
Aside from COVID-19, many biopharm companies are working to develop remedies for various ailments afflicting people. An example is Processa Pharmaceuticals Inc. (NASDAQ: PCSA), a company that focuses on acquiring drugs still in the development stage but with reasonable evidence of efficacy.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations
NEW YORK, Dec. 21, 2020 — Life Sciences Investor Forum today announced that the presentations from the December 17th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.
This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.
REGISTER OR LOGIN AT: https://bit.ly/2Wqsir2
December 17 th Presenting Companies:
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com .
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT
Life Sciences Investor Forum
John M. Viglotti
SVP Corporate Services, Investor Access
(212) 220-2221
johnv@lifesciencesinvestorforum.com
- POAI sent letter to shareholders requesting attendance at virtual Special Meeting on December 30, 2020
- Meeting will address reincorporation of POAI in Nevada
- Reincorporation expected to save POAI approximately $158,000 annually in state taxes
- Shareholders can vote online or by telephone, detailed instructions outlined in proxy materials
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, recently sent a letter to all shareholders urging them to attend a virtual Special Meeting of Stockholders (the “Meeting”). Originally scheduled for December 1, 2020, the Meeting will be reconvened on December 30, 2020 at 3:00 p.m. CST, where all shareholders will be requested by the Board of Directors and management of POAI to vote “FOR” the proposals put forward at the Meeting.
The Board of Directors and management of POAI are proposing that the corporation reincorporates in Nevada for the purpose of eliminating its obligation to pay the Delaware franchise tax of approximately $170,000 per year. By reincorporating in Nevada, POAI management believes that the company can save approximately $158,000 annually in state taxes.
“We are asking you to vote for allowing the company to reincorporate in the state of Nevada, moving away from Delaware,” writes POAI CEO Carl Schwartz (https://ibn.fm/UsMtz). “First and foremost, the reincorporation in Nevada will eliminate our obligation to pay the injurious annual Delaware franchise tax, which is currently equal to approximately $170,000 per year. We can save approximately $158,000 annually in state taxes by reincorporating in Nevada. Also, we believe that for the reasons described in the proxy materials, in general, Nevada law provides greater protection to our directors, officers and the company than Delaware law.”
In order for the reincorporation to be approved, the proposal must receive a “For” vote from the majority of outstanding shares of common stock of the company. At POAI’s recent Annual Meeting, the reincorporation vote received a larger amount of “For” votes than “Against” votes; however, the amount required for the vote to pass fell short for a majority of the outstanding shares. Management at POAI is urging all shareholders to vote their shares online or by telephone by following the instructions outlined in their proxy materials.
POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.
For more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based uranium mining company, today announced it has published its Sustainability Report, along with its Climate Change Policy, Human Rights Policy and Vendor Code of Conduct. According to the update, these, together with its other policies, describe the company’s ongoing commitment to the environment, worker health, public safety and social responsibility, including its important role in combating global climate change through producing and recycling carbon-free energy resources. Each of these documents is publicly available on the Energy Fuels website. “Energy Fuels might be the best untold clean energy and sustainability story in the U.S. today. We believe our recently published Sustainability Report tells this story, along with our commitments to human rights and corporate and social responsibility,” said Mark S. Chalmers, president and CEO of Energy Fuels. “We are proud of the growing roles we play in helping address global climate change, reducing air pollution, making clean energy technologies possible, and working to make the world a healthier and cleaner place.”
To view the full press release, visit http://ibn.fm/pVNf0
About Energy Fuels Inc.
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.MiningNewsWire.com
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com
MiningNewsWire is part of the InvestorBrandNetwork.
Angel CoFund, an investor backed by the UK government, holds a 5.5% stake in Small Pharma, a London-based neuropharmaceutical company. Small Pharma recently announced that it planned to list the firm on the Toronto Stock Exchange through Unilock Capital Corp, a Canadian capital pool, via reverse takeover.
The company’s objective is to raise $ 15.6 million, an equivalent of C$20 million, which will finance the clinical trial of dimethyltryptamine/DMT-assisted therapy treatment for depression. DMT is an active compound found in ayahuasca, an Amazonian psychedelic brew.
While Angel CoFund is a privately run organization, it is funded by a £100 million ($134 million) loan from the UK Department for Business, Energy and Industrial Strategy. The department recoups the gains made by the investor.
Angel CoFund expects to make a £2 million ($2.69 million) return on its investment once the company lists on the exchange. This means that the UK government will receive a seven-figure return on investment from its indirect investment in Small Pharma. The figures are based on Small Pharma’s prediction valuation, with Small Pharma adding that Angel CoFund had invested in it before the company had commenced its research on psychedelics.
After decades of not conducting research on psychedelic substances because of a general public backlash against psychedelic drugs, research in psychedelic substances and drugs has begun again with renewed zest. A variety of studies focus on the drugs themselves as well as their potential benefits on the human brain and body.
Like many other drugs — such as psilocybin, ketamine and MDMA — being studied by various biotech groups for their potential to treat PTSD and depression, DMT is still illegal in many nations in the world, including the UK.
However, Small Pharma’s chief executive Peter Rands recently stated in an interview that nearly one-third of the hundreds of millions of individuals across the globe who suffer from depression aren’t responsive to commonly prescribed antidepressant types known as selective serotonin reuptake inhibitors. He observed that the company’s objective is to provide alternative treatment.
Rands noted that the company is working to prove that DMT-assisted therapy could help patients learn to accept and deal with their underlying causes of depression rather than tempering their symptoms, which is what many antidepressants currently on the market do. Rands also stated that while DMT may not be as effectual as psilocybin, it is easier to administrate.
Prior ayahuasca studies have shown that the psychedelic helps to reduce symptoms of depression. However, more extensive placebo-controlled trials of DMT, its active compound, are required in order to convince both regulators and medical professionals of the psychedelic drug’s safety and efficacy.
Many North American companies are also poised to tap the opportunities presented by the emerging psychedelics industry. One such company is Cybin Inc. (NEO: CYBN), which is making inroads into not just the functional mushrooms market but also the medicinal psychedelics space.
NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Friday provided an update on its 49%-owned joint venture, PharmHouse Inc. Per the update, on Oct. 29, 2020, PharmHouse received a court order from the Ontario Superior Court of Justice to initiate a sale and investment solicitation process (“SISP”) to identify interest in, and opportunities for, a sale of, or investment in, all or part of PharmHouse’s assets or business. This may include a restructuring, recapitalization, or other form of reorganization of PharmHouse’s business and affairs. Phase one of the SISP concluded on Nov. 30, 2020, and a number of non-binding offers were received. PharmHouse, with the assistance of the monitor and the SISP advisor, has selected a number of parties to bring forward to the next phase of the SISP, and binding offers for phase two are due on or about Feb. 16, 2021.
In addition, Canopy Rivers today announced its entry into a definitive agreement with Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) pursuant to which, among other things, Canopy Rivers will transfer three portfolio assets to Canopy Growth in exchange for $115 million in cash and 3,750,000 common shares of Canopy Growth and the cancellation of all 36,468,318 Multiple Voting Shares (“MVS”) and the 15,223,938 Subordinate Voting Shares (“SVS”) of Canopy Rivers held by Canopy Growth (collectively, the “transaction”). On closing, the transaction will result in Canopy Rivers becoming a widely-held company and will unlock substantial value, providing it with significant additional cash resources and allowing it to pursue opportunities in the global cannabis market, including the United States. “This is a transformative transaction for our company that we believe provides substantial value to our shareholders through an enhanced cash position and strategic flexibility, and the collapse of our dual class share structure,” said Narbe Alexandrian, president and CEO of Canopy Rivers. “Following the closing of the transaction, we intend to shift our focus to pursuing other opportunities in the global cannabis market, where we believe that our new strategic focus and substantial balance sheet will allow us to successfully execute our revamped strategic plan.”
To view the full press release, visit http://cnw.fm/U6I4H and http://cnw.fm/PsSOQ
About Canopy Rivers Inc.
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging industry insights, in-house expertise and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders exposure to specialized and disruptive cannabis companies. Canopy Rivers’ mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, the company is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.
NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced the January 2021 launch of its Digital Connect Health Platform, a fully-integrated digital health care solution designed for both government and private sector. According to the update, the launch comes after continuous discussions and requests from government leaders, both provincial and federal, over the past seven months. “This has been nothing short of a massive undertaking over the past seven months,” said Loop Insights CEO Rob Anson. “In conjunction with key stakeholders who have been expressing the need for continued digital transformation within the health care sector, we have delivered a complete end-to-end digital solution that solves the challenge of decades of siloed data, a lack of connectivity and a lack of access. As a result, Loop provides governments and the private sector with the ability to connect their current legacy and antiquated systems. This is so revolutionary that it has attracted the attention of global technology companies and has positioned Loop for success within health care.”
To view the full press release, visit http://ibn.fm/xd7aK
About Loop Insights Inc.
Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.
NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
The race towards electrifying the roads is on, and for the most part, Europe has been ahead of the pack. Several countries around the globe have set timelines to ban the sale of new internal-combustion-engine (“ICE”) vehicles; most of those countries are in Europe, including France, Germany, Norway, the Netherlands and Denmark, among others. In September, California Gov. Gavin Newsom announced that by 2035, every new car sold in the state would be emission free, a move that could make California one of the largest electric vehicle (“EV”) markets on the globe.
Germany, however, is poised to surpass California, home to pioneering EV maker Tesla, as the largest EV market this year. According to a report by Schmidt Automotive Research from Berlin, drivers in Germany purchased 98,370 electric cars over the first nine months of 2020, more than a third of the EVs sold in California. This increase in pure electric vehicle sales can be attributed to a slew of recently extended purchase incentives by the government.
In most markets, electric vehicles are too expensive for consumers to buy outright, so authorities have taken to offering purchase incentives to lower the initial cost of purchasing an EV. Germany was already the largest market for electric vehicles in Europe after edging Norway out of the top spot in 2019, although Norway remains the country with the highest per-capita EV penetration in the world. Germany’s incentive program differs from most programs in Europe as it involves subsidies from both the government and the auto industry.
The German government initially offered a €4,000 ($4,863) discount for EVs with a starting price of less than €60,000 ($72,945) with half of the discount being covered by the auto industry. The incentives program was updated in 2019, with electric vehicles that cost less than €40,000 ($48,630) receiving a €6,000 ($7,294) discount and those going for between €40,000 and €60,000 getting a €5,000 ($6,079) discount. As part of a €5.9 billion ($7.172 billion) post-pandemic stimulus package to stimulate growth in the auto industry, the government updated the EV incentives program again.
Now electric vehicles that cost less than €40,000 get an extra €3,000 discount from the government, bringing the total subsidy to €9,000. EVs that are poised to benefit the most from this discount include Tesla Model 3, BMW i3, Peugeot 208 Electric, Hyundai Ioniq Electric, Hyundai Kona Electric, Kia Nero Electric, Renault Zoe and the yet-to-be-delivered Volkswagen ID.3.
Still on the topic of California’s EV industry, one global fintech company called Net Element (NASDAQ: NETE) is taking steps to merge with California-based EV manufacturer Mullen Technologies Inc. The resulting company from this merger will be interesting to watch.
NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
For more information, please visit https://www.GreenCarStocks.com
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com
Green Car Stocks is part of the InvestorBrandNetwork.
SOUTH SAN FRANCISCO, Calif., Dec. 17, 2020 — VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with potential to go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders, today announced that it commenced an underwritten public offering of units consisting of its common stock, par value $0.001 per share (the “Common Stock”), and its Series D convertible preferred stock (the “Series D Preferred Stock”). All securities to be sold in the offering are to be sold by VistaGen. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
The Series D Preferred Stock will be initially convertible into a specified number of shares of Common Stock at any time at the option of the holder, provided that no such conversion will be permitted until VistaGen’s stockholders approve an amendment to its articles of incorporation increasing the number of authorized shares of Common Stock in an amount sufficient to permit the conversion in full of the Series D Preferred Stock.
VistaGen intends to use the net proceeds from the offering for research, development and manufacturing and regulatory expenses associated with continuing development of PH94B, PH10, AV-101, and potential drug candidates to expand its CNS pipeline and for other working capital and general corporate purposes.
Jefferies LLC and William Blair & Company, L.L.C. are acting as joint book-running managers for the offering.
The public offering will be made pursuant to a shelf registration statement on Form S-3 (File No. 333-234025), previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective on October 7, 2019. The securities may be offered only by means of a prospectus supplement and accompanying prospectus that form a part of the registration statement. A preliminary prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov . When available, copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting: Jefferies LLC by mail at Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY, 10022 or by telephone at +1 877-547-6340, or by email at Prospectus_Department@Jefferies.com or William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606 or by email at prospectus@williamblair.com or by telephone at +1 800-621-0687.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About VistaGen
VistaGen Therapeutics, Inc. is a biopharmaceutical company committed to developing and commercializing innovative medicines with potential to go beyond the current standard of care for anxiety, depression and other CNS disorders. Each of VistaGen’s three drug candidates has a differentiated potential mechanism of action, has been well-tolerated in all clinical studies to date and has therapeutic potential in multiple CNS markets.
Forward-Looking Statements
Certain of the statements made in this press release are forward-looking, such as those, among others, relating to our expectations regarding the completion of the proposed public offering. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, risks and uncertainties related to whether or not we will be able to raise capital through the sale of shares of Common Stock and preferred stock, market and other conditions and the impact of the COVID-19 pandemic, general economic, industry or political conditions in the United States or internationally. There can be no assurance that we will be able to complete the proposed public offering on the anticipated terms, or at all. We will need to raise additional capital to fund our operations and may be unable to raise capital when needed, which would force us to delay, reduce or eliminate our product development programs or commercialization efforts. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. Other risks and uncertainties include, but are not limited to, issues related to: adverse healthcare reforms and changes of laws and regulations; manufacturing and marketing risks, including risks related to the COVID-19 pandemic, which may include, but are not limited to, unavailability of or delays in delivery of raw materials for manufacture of its CNS drug candidates and difficulty in conducting clinical trials; inadequate and/or untimely supply of one or more of its CNS drug candidates to meet demand; entry of competitive products; and other technical and unexpected hurdles in the development, manufacture and commercialization of its CNS drug candidates, as well as those risks more fully discussed in the section entitled “Risk Factors” in our most recent Annual Report on Form 10-K for the year ended March 31, 2020, and in our most recent Quarterly Report on Form 10-Q for the quarter and six months ended September 30, 2020, as well as discussions of potential risks, uncertainties, and other important factors in our other filings with the SEC. Our SEC filings are available on the SEC’s website at www.sec.gov. In addition, any forward-looking statements represent our views only as of the issuance of this release and should not be relied upon as representing our views as of any subsequent date. We explicitly disclaim any obligation to update any forward-looking statements.
Company Contact
Mark A. McPartland VistaGen Therapeutics Inc.
Phone: +1 (650) 577-3600
Email: IR@vistagen.com
Cannabis was one of the clear winners in the November 2020 ballot, with voters in five states approving legislation that allowed some form of cannabis use. Arizona was one of those states. Before to the elections, the traditionally red state had some of the most punitive cannabis policies in the country, with possession of even small amounts of marijuana classified as a felony. On Election Day, Arizonians voted overwhelmingly in favor of Proposition 207, a measure that would allow adults to possess a maximum of one ounce of marijuana as well as grow a maximum of six plants at a time for personal use.
A month later, state regulators have already released draft regulations to implement and run Arizona’s recreational cannabis program. The measure stipulates that the Arizona Department of Health Services, which would be in charge of regulating the cannabis program and issuing licenses, had to accept license applications starting Jan. 19, 2021. As such, regulators have been working hard to create guidelines for the state’s cannabis program within the relatively tight schedule that kicked off once the secretary of state officially certified the election results.
The Department of Health Services is expected to present at least one more version of draft regulations before finalizing the state’s cannabis rules. This version of draft regulations covers the timeline for license approvals, licensing fees, the state regulatory body’s structure, product labeling and other matters. Stakeholders will be able to submit feedback on the regulations via an online survey until Dec. 17, 2020. State regulators will use this feedback to amend and fine tune the cannabis regulations.
Thanks to the state’s experience with medical marijuana (Arizona legalized medical marijuana in 2010), regulators are confident they can draft cannabis regulations within the tight timeline outlined. Samuel Richard, executive director of the Arizona Dispensaries Association, has lauded the Department of Health Services for working hard to create an adult-use program “just a week and a half” after Arizona Governor Doug Ducey certified the election results. Medical marijuana operators in the state have an “open and collaborative” relationship with regulators, he says, and they hope the department will be receptive to their feedback.
The regulations are likely to be amended, he adds, with the Department of Health Services putting out at least one more draft based in the feedback it gets from the public. All in all, the cannabis regulations will not be finalized until early January.
Meanwhile, different cannabis products — not just those containing THC — are establishing themselves on the market elsewhere. For example, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) sells flavored as well as alkaline water, together with products enriched with CBD.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CNW420 is part of the InvestorBrandNetwork.
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, has achieved several accomplishments as recently published in its financial results for the third quarter of 2020. Among these, the company reported a rise in fiscal revenues to $24.5 million over the first nine months of 2020. A recent article discussing this quotes SGTM’s CEO and Director Tony Raynor in reference to the results. “I am proud of our team and the progress we have made this year in achieving these key milestones,” Raynor said. “We plan to proceed in a similar manner during the remaining quarter and end 2020 on a strong note. In keeping with that aim, we have already completed our two-year audit to commence our Form 10 process, which will enable us to begin 2021 as a fully reporting company and uplist accordingly.”
To view the full article, visit https://ibn.fm/C6ZUv
About Sustainable Green Team Ltd.
Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris, which has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic-growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial clients.
For additional information regarding SGTM’s operations, expansion plans and production facilities, view the company’s presentation. For more information about the company’s Mulch Manufacturing subsidiary, visit www.MulchMfg.com.
NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams declaring pivotal new insights into COVID-19 biology and disease processes. According to the update, all teams selected PBI’s Pressure Cycling Technology (“PCT”) platform for critical sample preparation steps to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in affected biochemical pathways. “The compelling history of scientists worldwide publishing on PBI’s PCT-based Barocycler system has resulted in its establishment as the method of choice for many teams who recognize that no compromise can be allowed in the critical stage of sample preparation as they work to ensure that the most complete, informative, robust and reproducible data are captured,” said Dr. Alexander V. Lazarev, chief science officer of PBI. “Recent publications and reports from three independent laboratories located on three different continents highlighted the importance of PBI’s highly effective and reproducible PCT sample preparation platform in studies designed to generate a more thorough understanding of the SARS-CoV-2 biology, etiology and human response to infection.”
To view the full press release, visit http://ibn.fm/t4Im4
About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling pressure-based solutions for the worldwide life sciences and other industries. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). Pressure BioSciences’ primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information about the company, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
A groups of investigators from various institutions in China and the United States have discovered a connection between major depressive disorder (MDD) and disturbances in the human gut microbiome. The study was published in the “Science Advances” journal.
The team of researchers studied samples of fecal matter from control groups and patients suffering from MDD. Major depressive disorder, also known as clinical depression, is a mood disorder that brings about a loss of interest or persistent feelings of sadness in an individual. The disorder affects how an individual behaves, thinks or feels, and may cause various physical and emotional problems.
Health practitioners believe that the disorder has a biological origin and is not just a reaction to events. The team of researchers argued that they had discovered evidence that connects symptoms of the disorder to problems with an individual’s gut microbiome. The study involved the collection of fecal samples from 155 individuals who do not have the depressive disorder and 156 individuals who have been diagnosed with MDD.
The scientists then conducted a genetic analysis of each of the samples collected in order to determine the microbes and other materials in the samples. Additionally, the researchers conducted an extensive gas chromatography mass spectrometry analysis on the samples in a bid to discover more about their composition.
The researchers noted that in there were differences in the components that were found in the samples, between those from individuals who did not have the disorder and those who did. Specifically, they discovered 3 bacteriophages, 50 fecal metabolites and 47 bacterial species that were different.
In addition, they also determined that patients with the depressive disorder had lower levels of bacteria from the Blautia and Eubacterium species and higher levels of different bacteria from the Bacteroides genus. This led the researchers to believe that major depressive disorder may be connected to problems with gut microbiome.
The researchers suggest that heightened levels of Bacteroides in the microbiome can explain why a lot of patients who suffer from MDD have associated inflammation and higher cytokine levels. The investigators noted that while the current method used to diagnose MDD is an interview, their findings may be useful in developing an additional test to confirm the disorder. This would be by conducting a screening test to assess for the presence of particular elements in the gut microbiome.
Aside from major depressive disorder, different cancers afflict millions of people around the world, and many companies are hard at work seeking better ways to treat these diseases. One firm that is at the forefront of cancer research is Predictive Oncology (NASDAQ: POAI). This company focuses on using AI and data analytics to develop personalized remedies for cancer sufferers.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
- Precision medicine is emerging approach to disease prevention, treatment that incorporates individual’s distinctive characteristics.
- New approach allows doctors, researchers to predict more accurately which treatments may work better.
- Helomics’ database, largest of its kind, is comprised of ovarian, head and neck, colon and pancreas tumors.
Science has discovered that thumbprints and DNA aren’t the only biological elements that make individuals unique. In fact, ears, eyes, tongues and even the way a person walks is distinctive, unlike anybody else in the world (https://ibn.fm/SJX27). Moreover, the things that make people different from each other don’t stop at physical characteristics. Predictive Oncology (NASDAQ: POAI) is building a business around precision medicine, an emerging approach to disease prevention and treatment that identifies the variability in genes, environment and lifestyle for each individual, and then uses that information to provide individualized treatments designed to ultimately improve patient outcomes (https://ibn.fm/Va9HX).
“This new approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people,” explains a MedLinePlus article. “It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.”
POAI realizes that “just genomics” is not enough to deliver personalized therapeutic options. The company believes that a multi-omic approach to disease, or one that gathers data from multiple levels such as genome, epigenome, transcriptome, proteome and metabolome, offers a much greater chance of success. With that in mind, Predictive Oncology is addressing cancer, specifically ovarian cancer, by leveraging the synergies of two of its wholly owned subsidiaries — Helomics and TumorGenesis — to bring precision medicine to the space.
One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome. The company accomplishes this through its subsidiary Helomics and by using its proprietary TumorSpace knowledge base of 150,000 tumor drug response profiles gathered from more than 15 years of clinical testing.
“We have developed a unique technology that combines our clinically validated primary tumor cell assay and drug response data . . . together with proven artificial intelligence (AI) to allow us to test potential drugs against patient tumor cells, much earlier in the drug discovery process,” the company explains (https://ibn.fm/GRRXb). “We believe this patient-centric approach will significantly improve the success of translating compounds into the clinic, saving time, cost, and most importantly getting therapies to patients more quickly.”
Helomics’ database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. The company’s CLIA-certified lab provides testing that assists oncologists in identifying personalized patient treatment options. TumorGenesis is developing a new approach to growing tumors in the laboratory without the use of rats or mice. This exclusive methodology “fools” the tumor into thinking it is still in the body; therefore, it reacts as it naturally would, increasing the accuracy of the biomarker. These biomarkers are then used in TumorGenesis’ Oncology Capture Technology platforms, which isolate and help categorize an individual patient’s heterogeneous tumor samples. The process provides critical information that can be used to develop patient-specific treatment options.
For more information on Predictive Oncology, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
NEW YORK, Dec. 17, 2020 — via InvestorWire — Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.
To view the full publication, “It’s Elemental — Restoring the U.S. Rare Earth Element Supply Chain,” please visit: https://nnw.fm/7GSZE
The United States was once a thriving producer of rare earth elements (REEs), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world.
Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR ) is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world.
About Energy Fuels Inc.
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com .
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate comm
NEW YORK, Dec. 17, 2020 (GLOBE NEWSWIRE) — via InvestorWire — Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.
To view the full publication, “It’s Elemental — Restoring the U.S. Rare Earth Element Supply Chain,” please visit: https://nnw.fm/7GSZE
The United States was once a thriving producer of rare earth elements (REEs), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world.
Against this backdrop, the U.S. government is committed to ending its dependence upon China for REEs, and Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR ) is among the leaders with projects that intend to re-ignite REE production in the U.S., which in Energy Fuels’ case, is expected as soon as early 2021. In December 2020, the company advanced its entry into the REE market by inking a three-year supply agreement with the Chemours Company (NYSE: CC) to acquire a minimum of 2,500 tons per year of natural monazite sand ore, one of the highest-grade and highest-value rare earth minerals in the world.
About Energy Fuels Inc.
Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and anticipates commencing commercial production of rare earth element (“REE”) carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming, and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year, has the ability to produce vanadium when market conditions warrant and is completing final test-work for the production of REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com .
NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.
NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
unication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness.
NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, this morning announced that it has received US Food and Drug Administration (“FDA”) approval of its Investigational New Drug (“IND”) application on its lead product candidate Berubicin for the treatment of Glioblastoma Multiforme (“GBM”). This approval signifies a crucial step for the company in launching a potentially pivotal trial to investigate the efficacy of Berubicin in adults with GBM who have been unsuccessful with first-line therapy. In addition, following recent correspondence with the FDA, the company has modified the previously disclosed trial design, naming overall survival (“OS”) as the primary endpoint of the study. “Since becoming a public company, our clear focus has been on advancing the clinical development of Berubicin. We will now rapidly move to initiate our Phase 2 trial of Berubicin for adults with GBM and expect to begin enrolling patients in the first quarter of next year,” CNS Pharmaceuticals CEO John Climaco stated in the news release. “The company will transform within the next several months as Berubicin becomes the subject of up to three active clinical trials, which include our randomized, controlled Phase 2 trial in the U.S., and 2 trials planned by our sublicensee WPD in Poland. We are entering an area with significant unmet medical need since the current treatment paradigm for GBM remains bleak, as this aggressive and currently incurable form of brain cancer continues to claim high mortality rates. We have a tremendous opportunity ahead of us as we continue our mission to improve patient outcomes for GBM and build on the promising results demonstrated by Berubicin in its Phase 1 clinical trial.”
To view the full press release, visit https://ibn.fm/s44FT
About CNS Pharmaceuticals Inc
CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the United States, while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. The company’s second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information about the company, please visit www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
NetworkNewsWire Editorial Coverage: COVID-19 has been a major driver behind explosive technological advances this year as companies have focused on doing what they do best — but even better. While some advancements have targeted saving lives, others have focused on saving livelihoods, as financial stability and security can be almost as important as health in today’s world of emotional and economic fear and uncertainty. The pandemic has transformed the world in many ways, including bringing data collection and digital technologies to the forefront of a socially distanced world. With this in mind, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) (Profile) recently made history by offering the first-ever, end-to-end venue-tracing and management solution. A provider of contactless solutions and artificial intelligence aimed at driving automated marketing, venue management and tracing to the brick-and-mortar space, Loop made its mark as it created a “bubble” platform for NCAA basketball to take place in Nevada and Florida. Using Loop Insights’ venue-tracing platform combined with revised safety protocol, numerous games were played over several days and in several venues without a single case of COVID-19 being reported. Data collection, automated marketing and other transformational technology is driving success for other industry movers and shakers as well. The cloud data platform Snowflake Inc. (NYSE: SNOW) recently announced a partnership with the state of California to deliver fast, frictionless public access to COVID-19 data via the Snowflake Data Marketplace. Automated marketing is key to Shopify Inc. (TSX: SHOP) (NYSE: SHOP), the leading multi-channel commerce platform that just unveiled the latest in commerce technology. Commerce is also at the heart of ads, one of the main services provided by Facebook Inc. (NASDAQ: FB). And in terms of sheer ability to manage and aggregate data, Nielsen N.V. (NYSE: NLSN) just announced plans to launch Nielsen One, a single, cross-media solution to drive more comparable and comprehensive metrics across platforms.
- The idea of creating a vast, complete bubble might seem unrealistic and financially prohibitive — but it’s neither.
- Loop’s system includes all the requisite hardware, software, rapid mobile testing and integrated lab results.
- With the whole world watching, Loop Insights may have come out the clear winner at #VegasBubble, #BeachBubble.
A Bubble of Safety, Protection
Once reserved for the most sick and frail, a “bubble” means something different today than it ever has before. With the COVID-19 pandemic topping 16 million cases and the death count nearing 300,000, bubbles today are viewed as places of safety and protection for just about everyone, regardless of whether they are traveling, playing or watching sports, or even attending school or working at the office.
The idea of creating such a vast and complete bubble might seem unrealistic — and financially prohibitive. However, real-world experience has proven otherwise. In an attempt to save its 2020 season, the NBA invested $150 million to create the “Disney World Bubble,” which “recouped $1.5 billion in revenue that might have been lost had the season ended when COVID-19 paused it on March 11. And no positive tests came out of the bubble among players, staff and media.” After losing nearly $1 billion by scrapping its popular March Madness tournament this year, the NCAA is looking to avoid a repeat.
The Loop System
The NCAA has substantial proof that a bubble is effective after partnering with Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) and its turnkey venue-tracing solution. The collegiate sports organization planned and put together the #VegasBubble in Nevada and the #BeachBubble in Florida during the 10 days of the basketball season, which included 11 NCAA Division 1 men’s and women’s teams.
An integral part of the plan was Loop’s system, which included all the requisite hardware, software, rapid mobile testing and integrated lab results. All users have to do is register and receive a wallet pass on their mobile phones and then check in at designated contactless devices. After that, location-based beacons, GPS and Internet of Things (“IoT”) technology takes over.
The system is infinitely scalable and has proven high adoption rates compared to other apps because additional hardware or software isn’t required. The system uses the mobile wallet that already exists on a user’s mobile device. Loop uses this same near-field communication (“NFC”) technology backed by Apple and Google.
And in a world where personal information is paramount, all collected data is de-identified and securely stored in Loop’s data portal where its artificial intelligence (“AI”) technology shares essential details such as movements, active users, occupancy levels, promotions and more. In addition, Loop’ s real-time messaging keeps users up-to-date on critical information and alerts individuals who are at risk or in need of a COVID-19 rapid test.
Indisputable Data
The world has been devastated by COVID-19 in so many different ways. And while healthy is paramount, it has becoming increasingly evident that the ability to enjoy life — and earn a living — cannot be underestimated. With that in mind, the value of sports at all levels is rising. Teams, schools, leagues and ancillary businesses that depend on sports cannot afford to see seasons canceled. Loop and its partner, bdG Sports, one of the nation’s leading content providers in college basketball programming, clearly proved that they don’t have to be.
The two innovation leaders worked closely with the NCAA and host sites to identify best practices under new health and safety protocols and implement the first-ever, end-to-end COVID-19 venue solution in a live environment. Given the months-long dearth of live events, the ability to plan, attend and enjoy a wide range of sports events in almost unlimited venues holds almost irresistible allure. Certainly Loop’s bubble success has garnered the company worldwide attention.
It’s not an exaggeration to say that the whole world was watching to see if Loop’s claims that its technology could protect players and staff throughout the week-plus of men’s and women’s Division I games would stand up. And as teams battled over the ball at MGM Grand Garden Arena, Mandalay Bay Events Center and T-Mobile Arena in Las Vegas and Hertz Arena and Alico Arena in Fort Meyers, Florida, Loop may have come out the clear winner.
The data is indisputable. Loop’s system did not suffer any outages, and user experiences proved to be as seamless as anticipated. The #BeachBubble alone over seven days consisted of:
- Total locations: 14
- Total enrolled users: 553
- Total check-ins: 3,830
- Tracing checks: 2 highly detailed reports were generated in 15 minutes for potential infected cases, with both tests confirmed negative.
“[We] hit it out of the park,” Loop reported, noting that its bubble solution “is nothing short of world-class.” Armed with these successes and with few companies keeping up, Loop Insights is already in negotiations to re-open major sporting events from North America to Australia.
“Loop’s venue bubble platform has provided us with the peace of mind to move forward with our return-to-play efforts in college basketball safely,” said bdG Sports CEO Brooks Downing. In addition to safety and providing an aggregated report on activity via the Insights platform, companies obtain a competitive marketing edge because the data drives Loop’s Engage platform to generate real-time targeted promotions to event attendees.
And protection and safety isn’t the only thing Loop provided during the NCAA bubbles. In fact, the Loop system also provides sponsors with new revenue stream opportunities. The system also offers event sponsors the ability to add highly targeted promotions to Loop’s venue-tracing wallet pass — the perfect way to ensure that event attendees and participants see personalized promotions.
This innovative technology could mean the return of live sports, conventions, concerts and festivals. Loop recently partnered with SimpliFlying, noting that discussions about possible uses have “significantly advanced” to offer travel bubbles with fully integrated rapid testing, tracing and notifications removing the need for mandated quarantines.
Technology, Data Come Together
Clearly the time has never been better for technology and data to come together, whether in the form of data collection, automated marketing or other transformational applications and uses. Other companies have clearly recognized the opportunity as well and are offering powerful products and services that meet compelling needs.
California has been using Snowflake Inc.’s (NYSE: SNOW) single, integrated cloud data platform to store and analyze a multitude of data sets, including the current number of COVID-19 cases across the state, total suspected cases, number of residents receiving treatment in a hospital ICU, available and in-use hospital beds and ventilators, and the demographics of COVID-19 patients. “The State of California’s response to the COVID-19 emergency has been enhanced greatly by the ability to share, collaborate, and communicate data and information in new ways that are meaningful to health professionals and allied support entities during this crisis,” said Scott Gregory, the state technology department’s chief technology innovation officer.
Shopify Inc.’s (TSX: SHOP) (NYSE: SHOP) is transforming commerce by announcing platform enhancements and updates focused on giving direct-to-consumer brands everything they need to build and manage a business. According to the company, innovations include a newly updated Shopify Plus platform for enterprise brands, more global capabilities, and for the first time, Shopify is expanding its offering with a fulfillment network that will allow merchants of all sizes to deliver their products fast and at a low cost.
A huge portion of Facebook Inc.’s (NASDAQ: FB) revenue stems from its ads; the company’s most recent financials — for Q3 2020 — show more than $21 billion in ad revenue. “We had a strong quarter as people and businesses continue to rely on our services to stay connected and create economic opportunity during these tough times,” said Facebook founder and CEO Mark Zuckerberg, Facebook founder and CEO. “We continue to make significant investments in our products and hiring in order to deliver new and meaningful experiences for our community around the world.”
And just last week Nielsen N.V. (NYSE: NLSN) announced its exclusive cross-media solution, called Nielsen ONE, also targeting connecting advertisers and consumers in an easier, faster approach. As audiences move seamlessly between linear, streaming and digital, advertisers are demanding a single, deduplicated view of their audience across all platforms and mediums, while publishers want to provide more ad options for buyers and improve the overall viewer experience, Nielsen explained. Nielsen One provides visibility into audiences by platform and unique demographic profiles of each publisher.
With all the huge strides that companies are taking in efforts to provide the world with stability and security, there’s reason to look toward the future with optimism. The advancements taking place today will almost certainly continue to have widespread use and life-changing applications moving forward.
For more information about Loop Insights, please visit Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF).
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.
The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.
NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.
Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced its entry into a global partnership agreement with NTT DATA Corp of Japan (TYO: 9613). NTT DATA is a global leader in technology services and a top-ranked global Internet of Things (“IoT”) consulting and system integration services company, with US$20 billion in revenues in 2020. Under the agreement, Loop and NTT DATA intend to combine their respective strengths to create new recurring revenue models for both companies. “Our partnership with NTT establishes Loop Insights as a global provider of IoT solutions for Venue Bubbles and Artificial Intelligence-driven automated marketing,” said Loop Insights CEO Rob Anson. “As a result of this partnership, Loop will be exposed to global opportunities never thought possible earlier this year. For example, Loop’s successful live deployment of its Venue Bubble solution and its published capabilities with respect to its Travel Bubble solution will be the subject of work on major projects with NTT DATA. We thank William and his team for their confidence and look forward to accomplishing incredible things together in 2021.”
To view the full press release, visit https://ibn.fm/4moWa
About Loop Insights Inc.
Loop Insights is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network. For more information, visit the company’s website at www.LoopInsights.ai.
NOTE TO INVESTORS: The latest news and updates relating to RACMF are available in the company’s newsroom at http://ibn.fm/RACMF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Siyata Mobile (NASDAQ: SYTA, SYTAW), a business-to-business (“B2B”) global vendor of next-generation cellular solutions, today announced the commercial launch of its Uniden(R) Mobile Coverage Kit (“MCK”). The MCK is designed to empower first responders and government agencies to stay connected even in remote areas where cellular coverage is weak. “Now more than ever, we see how critical government agencies and first responders are keeping our communities safe,” said Siyata CEO Marc Seelenfreund. “The Uniden(R) Mobile Coverage Kit ensures that, if used, these heroes may have exceptional cellular coverage to stay connected as they respond to emergency situations. We are very pleased to add this unique solution to our booster portfolio and expect it to be another contributing factor to our anticipated revenue growth for 2021.”
To view the full press release, visit http://ibn.fm/Za4D5
About Siyata
Siyata Mobile Inc. is a B2B global vendor of next-generation push-to-talk over cellular (“PTT”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to improve communication, increase situational awareness and save lives.
Its portfolio of enterprise cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible.
Visit www.SiyataMobile.com and www.UnidenCellular.com to learn more.
NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, will partner with a University of Michigan 2021 startup cohort, TechLab at Mcity, to further develop its automotive vision system designed for Advanced Driver Assistance Systems (“ADAS”) and autonomous vehicles. The one-year partnership program entails FRSX collaborating with a group of students from technical departments at the University of Michigan; the group, which will be mentored by Foresight’s head of algorithm and leading team members, is concentrating on the development, demonstration and deployment of key autonomous vehicle technologies. As part of the program, Foresight will have access to a test facility, where the company can run short-cycle demonstrations for local prospects. “We are thrilled to join TechLab at Mcity and to have access to a leading mobility research and test facility,” said Foresight CEO Haim Siboni in the press release. “We are hopeful that collaboration with TechLab at Mcity will enhance Foresight’s vision system capabilities to achieve outstanding performance in any lighting and harsh weather conditions, reduce the rate of road accidents and save lives.”
To view the full press release, visit http://ibn.fm/jy0cF
About Foresight Autonomous Holdings Ltd.
Founded in 2015, Foresight is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident-prevention solution based on real-time spatial analysis of clients’ movements. The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the Advanced Driver Assistance Systems (“ADAS”) and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology. For more information, visit the company’s website at www.ForesightAuto.com.
NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Blue Hat Interactive (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, has announced that Fuzhou Csfctech Co. Ltd. (Csfctech), a company it is in the process of acquiring a 51% interest in, is testing new gaming products. Csfctech is targeting overseas markets for the five new products it is developing. The five new games include Qule King of Fishing War, a competitive fish-catching game with multiple players; Qule Battle the Landlord, a music selection puzzle game; MOMO Remove, a brain teaser game; MOMO Link, a game of puzzle elimination; and MOMO Hexagon, a block matching game. The acquisition of Csfctech marks a significant step Blue Hat’s development of its mobile games unit, one of three areas the company is focusing on; the other two are AR gaming and interactive education. “We are confident that we can drive the rapid growth of the gaming business segment,” said Blue Hat CEO Xiaodong Chen in the press release. “Looking at the moment, the boom in the gaming market is evident, even after the industry shock in the first half of 2020. We saw a rapid increase in the timing of individuals entering the gaming space, which we intend to capitalize on in the coming months. With the continuous upgrading of the game business and the launch of new products, Csfctech will provide more adequate promotional resources and new gaming content for players. For the already launched online games, we will also invest more energy and capital to provide regular updates that will be both regional and seasonal in nature, and ultimately drive user growth. We believe the totality of all of our efforts will help drive revenue growth, margin expansion, and net profits in our mobile game development segment.”
To view the full press release, visit http://ibn.fm/16jL3
About Blue Hat Interactive Entertainment Technology
Blue Hat Interactive is a producer, developer and operator of AR interactive entertainment games and toys in China , including interactive educational materials, mobile games, and toys with mobile game features. The company’s interactive entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information about the company, please visit https://ir.BlueHatGroup.com/investor-relations.
NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) has announced voting results from its annual general and special shareholder meeting (“AGSM”). The virtual-only meeting was held Tuesday, Dec. 15. Earlier this year, on Oct. 30, 2020, company management sent out an information circulate to shareholders for their consideration outlining the matters to be considered and approved during the meeting; all items on that list were approved by the required majority of votes. Included in the voting was the election of directors; the following individuals were voted in: Jeffrey J. Scott, Marc Bertrand, Nicholas G. Kirton, Caroline MacCallum and Jacques Dessureault. In addition, shareholders approved the the appointment of KPMG LLP as company auditor and authorized company directors to fix their remuneration, the amended and restated Employee Stock Purchase Plan, the amended and restated Restricted Share Unit Plan, and the amended and restated By-law No.1. Worth noting was the total number of common shares of the company represented by shareholders and by proxy at the Meeting: 152,035,835, or 34.7% of total issued and outstanding common shares. A recording of the meeting can be found on the company website.
To view the full press release, visit http://ibn.fm/3qvtE
About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman is a premium certified organically grown cannabis company focused on the health and wellness market. Its organic cannabis is cultivated in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flower and oil, and recently launched a series of next–generation cannabis products such as hash, vapes, organic teas and dissolvable powders. Through its European subsidiary, HemPoland, the company also distributes premium-hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale. For more information about the company, please visit www.TGOD.ca.
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has contracted with a leading manufacturer to produce its first cannabinoid, cannabigerol (“CBG”); the first production run is slated for early 2021 and will result in commercial quantities of Willow’s ultra-pure CBG. The product will be manufactured in Europe. In addition, Willow announced plans to run a second 500-litre pilot this month in order to meet demand for customer samples and streamline the production process. These announcements mark significant progress for the company in its strategic commercialization plan. Based on progress so far, the company noted that it anticipates seeing revenue generated from this commercialization as early as Q2 2021, which is six months ahead of expectations. “Advancing to commercial-scale production is the final step in our transition to becoming a revenue generating company,” said Willow president and CEO Trevor Peters in the press release. “Our ability to begin this important milestone ahead of expectations is a testament to our exceptional scientific and commercially minded team. We are seeing strong interest in our CBG samples and are working closely to understand the needs of potential customers. Once our commercial scale multi-kilogram run is complete, Willow will be uniquely positioned to take advantage of what many industry experts are projecting to be a multi-billion dollar market.”
To view the full press release, visit: https://www.cnw.fm/by0sZ
About Willow Biosciences Inc.
Willow is a Canadian biotechnology company based in Vancouver, British Columbia , that produces high-purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is on the production of cannabinoids for the treatment for pain, anxiety, obesity and brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high-purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information about the company, please visit www.WillowBio.com.
NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com
CannabisNewsWire is part of the InvestorBrandNetwork.
WrapTechnologies (NASDAQ:WRAP), an innovator of modern policing solutions, has closed an asset purchase agreement with NSENA Inc. NSENA is a developer and provider of a law-enforcement training platform that uses immersive virtual reality computer graphics along with proprietary software, hardware and content. NSENA’s content library contains 47 training modules and is one of the largest such resources available that focuses on law enforcement. The company develops training modules that cover a wide array of skills and scenarios applicable to law-enforcement officers; modules include topics such as de-escalation, conflict resolution and all levels of use-of-force. NSENA also has a strong pipeline of prospective customers, contractors and licensees. According to the agreement, the VR business will be rebranded as WRAP Reality(TM). WRAP will host a live webinar today (Wednesday, Dec. 16) at 5 p.m. ET to discuss NSENA and its VR platform. “This acquisition firmly positions WRAP in the multi-hundred-billion-dollar virtual reality training market and also complements our BolaWrap law enforcement training solution being delivered by our master instructors and WRAP Training Academy,” said WRAP president and interim CEO Tom Smith in the press release. “We are excited to work with the NSENA team to add new features and capabilities to our VR offering, expand our sales team and grow the VR platform and BolaWrap revenues. With our previously announced relationship with the National Tactical Officers Association (‘NTOA’), we plan to offer a fully-integrated training and training record management solution targeting agencies of all sizes that until now have limited choices to meet the ever-growing public safety training demands.”
To register for the webinar, visit https://ibn.fm/DR2m6
To view the full press release, visit http://ibn.fm/g4rL7
About Wrap Technologies Inc.
WRAP is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a distance from 10 to 25 feet. Developed by award-winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement in safely and effectively deescalating encounters, especially those involving an individual in crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth and Oak Ridge. For more information about the company, please visit www.WRAP.com.
NOTE TO INVESTORS: The latest news and updates relating to WRAP are available in the company’s newsroom at http://ibn.fm/WRAP
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.
